A study on strategies for the prevention and treatment of metabolic syndrome in Chinese medicine and the preliminary construction of a predictive model for cardiovascular disease risk - a prospective cohort study

Phase 1

• Conditions: Metabolic syndrome

• Registration Number: ITMCTR2022000037
• Lead Sponsor: Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) age 30-80 years, gender not limited;
(2) meet the diagnostic criteria for metabolic syndrome and any of the above TCM evidence types;
(3) have good compliance;
(4) sign the informed consent form.

Exclusion Criteria

(1) Exclusion of other primary diseases causing (chronic kidney disease, chronic liver disease, hypothyroidism) abnormalities in blood glucose, lipids and blood pressure.
(2) Combination of severe cardiovascular and cerebrovascular diseases, such as heart failure, severe hypertension, cerebral haemorrhage, etc.
(3) Combined with severe liver function abnormalities (ALT or AST reaching more than 3 times the upper limit of normal), endocrine diseases, malignant tumours and autoimmune diseases
(4) Women who are pregnant, preparing for pregnancy or breastfeeding.
(5) Allergy and hypersensitivity to the components of the drug used in this study.
(6) Those who are participating in other clinical trials or have participated in clinical trials of other drugs for less than 1 month.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ipid Indicators;Waist Circumference;Blood glucose indicators;Blood Pressure;

Secondary Outcome Measures

Name	Time	Method
Stool Routine;Blood count;Obesity Indicators;Urine Routine;Complete Biochemistry;Abdominal ultrasound;Carotid ultrasound;Cardiac ultrasound;